Boston Scientific, Urologix Amend Targis European Distribution Deal
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will help fund Urologix' market development efforts in Europe for the Targis microwave therapy for benign prostatic hyperplasia by paying the company $1-2 mil. dollars per year through June 2001.